Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

At just three months, before dose titration was over, participants on semaglutide had a noted decreased risk for stroke, heart attack, or cardiovascular death, with additional benefits at six months.

Early heart benefits before major weight changes One of the most intriguing aspects of semaglutide’s cardiovascular impact is the timing of these benefits. Recent analysis of extensive clinical ...

The following is a summary of “Oral semaglutide for the treatment of obesity: a retrospective real-world study,” published in ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular ... major cardiovascular events, with significant benefits already evident by the first 6 months, and for some ...

The list of benefits for Novo Nordisk's semaglutide keeps getting longer. Now, it seems the GLP-1 agonist could help patients with heart failure, adding to earlier studies showing it can treat ...

In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular ... major cardiovascular events, with significant benefits already evident by the first 6 months, and for some ...

"I won't hold my breath, because most of my patients do relapse at some point, but I was really excited about this curve when ...